HOUSTON: As the senior care industry gains more traction among both veteran and fledgling tech companies, one startup is poised to take the aging services sector by storm.
And it’s not producing wearables or health monitoring devices. It’s using 3-D bioprinting technology to create living tissues that can be used for testing new drugs and could eventually replace damaged tissues — and perhaps organs — in the human body.
That’s the idea behind BioBots, which had a sort of Facebook-esque start in a college last year.
Though BioBots is still in its early development stages, co-founder Danny Cabrera assures that its 3-D bioprinting technology “is going to change everything about aging.”